Ajanta Pharma (AJANTPHARM) — Financial Results

Ajanta Pharma announced that its trading window will close on 1 July 2026 for insider transactions until 48 hours after the quarterly results for June 30 2026 are declared, per SEBI regulations and company code of conduct.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AJANTPHARM ✨ Ask AI About This

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹39,694.55 Cr P/E: 37.6 ROE: 23.3% ROCE: 29.4%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

💡 Ask AI about this filing

"How does this financial results affect Ajanta Pharma Limited's outlook?" "What did Ajanta Pharma Limited announce on 26 June 2026?" "Is this positive or negative for AJANTPHARM?"

Ask AI Free →

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

🔥 Also filed on 26 June 2026

SAPPHIRE Sapphire Foods India Limited Annual Report PURVA Puravankara Limited Announcement PRIMO Primo Chemicals Limited Announcement RAJSREESUG Rajshree Sugars & Chemicals Limited Annual Report RAJESHEXPO Rajesh Exports Limited Announcement SAPPHIRE Sapphire Foods India Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.